IgG anti-toxoplasma antibodies among asymptomatic HIV-infected patients in Marrakesh-Morocco

Acta Tropica

Volumn 123, Issue 1, 2012, Pages 49-52

  Addebbous, Amal ^a   Adarmouch, Latifa ^b   Tali, Abdelali ^a   Laboudi, Majda ^c   Amine, Mohamed ^b   Aajly, Lahcen ^d   Rhajaoui, Mohamed ^c   Chabaa, Laila ^a   Zougaghi, Laila ^a  

^a Centre hospitalier universitaire Mohammed VI   (Morocco)

^b University Cadi Ayyad Faculte de Medecine et de Pharmacie de Marrakech   (Morocco)

^c INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^d Centre hospitalier régional Avenzoer   (Morocco)

Author keywords

HIV; Marrakesh; Morocco; Seroprevalence; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY; DISEASE PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS; PARASITIC DISEASE; RISK FACTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOROCCO; OPPORTUNISTIC INFECTION; SEROLOGY; SEROPREVALENCE; TOXOPLASMOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, PROTOZOAN; ASYMPTOMATIC DISEASES; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOROCCO; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

MARRAKECH [(CTY) MARRAKECH-TENSIFT-AL HAOUZ]; MARRAKECH-TENSIFT-AL HAOUZ; MOROCCO;

HUMAN IMMUNODEFICIENCY VIRUS; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84860585778     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2012.02.070     Document Type: Article

References (20)

1. Admou B., Elharti E., Oumzil H., Addebbous A., Amine M., Zahlane K., Soraa N., Zougaghi L., Haouach K., Tassi N., Aajly L., Chabaa L., El Aouad R. Clinical and immunological status of a newly diagnosed HIV positive population, in Marrakesh, Morocco. Afr. Health Sci. 2010, 10:325-331.
2. Bastien P. Molecular diagnosis of toxoplasmosis. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:S205-S215.
3. Bouratbine A., Siaia E., Chahed M.K., Aoun K. Sero-epidemiological data about toxoplasmosis in the north of Tunisia. Parasite 2001, 8:61-66.
4. Brindle R., Holliman R., Gilks C., Waiyaki P. Toxoplasma antibodies in HIV-positive patients from Nairobi. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:750-751.
5. Daryani A., Sharif M., Meigouni M. Seroprevalence of IgG and IgM anti-Toxoplasma antibodies in HIV/AIDS patients, Northern Iran. Asian Pac. J. Trop. Med. 2011, 4:271-274.
6. Derouin F., Leport C., Pueyo S., Morlat P., Letrillart B., Chêne G., Ecobichon J.L., Luft B., Aubertin J., Hafner R., Vildé J.L., Salamon R. Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS 1996, 10:1521-1527. (ANRS 005/ACTG 154 trial group).
7. El Mansouri B., Rhajaoui M., Sebti F., Amarir F., Laboudi M., Bchitou R., Hamad M., Lyagoubi M. Séroprévalence de la toxoplasmose dans la ville de Rabat au Maroc. Bull. Soc. Pathol. Exot. 2007, 100:289-290.
8. Grant I.H., Gold J.W., Rosenblum M., Ntedzwiecki D., Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990, 4:519-521.
9. Hellerbrand C., Goebel F.D., Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:869-872.
10. IPA, Annual Report of the "Institut Pasteur d'Algérie", 2009. (www document). http://www.pasteur.dz/site/presentation.php%3Fpage=72.
11. Karkouri M. L'infection à VIH au Maroc. Ann. Pathol. 2008, 28:113.
12. Laboudi M., El Mansouri B., Sebti F., Amarir F., Coppieters Y., Rhajaoui M. Facteurs de risque d'une sérologie toxoplasmique positive chez la femme enceinte au Maroc. Parasite 2009, 16:71-72.
13. Lindström I., Kaddu-Mulindwa D.H., Kironde F., Lindh J. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda. Acta Trop. 2006, 100:218-222.
14. Machala L., Kodym P., Rozsypal H., Stanková M., Sedlácek D. Recommendation for diagnostics and therapy of toxoplasmosis in persons with HIV infection. Klin. Mikrobiol. Infekc. Lek. 2007, 13:248-252.
15. Masur H., Kaplan J.E., Holmes K.K. Guidelines for preventing opportunistic infections among HIV-infected persons-2002, recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann. Intern. Med. 2002, 137:435-478.
16. Meisheri Y.V., Mehta S., Patel U. A prospective study of seroprevalence of toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J. Postgrad. Med. 1997, 43:93-97.
17. Naito T., Inui A., Kudo N., Matsumoto N., Fukuda H., Isonuma H., Sekigawa I., Dambara T., Hayashida Y. Seroprevalence of IgG anti-Toxoplasma antibodies in asymptomatic patients infected with human immunodeficiency virus in Japan. Intern. Med. 2007, 46:1149-1150.
18. Nissapatorn V., Lee C., Quek K.F., Leong C.L., Mahmud R., Abdullah K.A. Toxoplasmosis in HIV/AIDS patients: A current situation. Jpn. J. Infect. Dis. 2004, 57:160-165.
19. Raffi F., Franck J., Pelloux H., Derouin F., Reliquet V., Ambroise-Thomas P., Aboulker J.P., Leport C., Dumon H. Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis. Diagn. Microbiol. Infect. Dis. 1999, 34:51-56.
20. Zangerle R., Allerberger E., Pohl P., Fritsch P., Dierich M.P. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med. Microbiol. Immunol. 1991, 180:59-66.